<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00331292</url>
  </required_header>
  <id_info>
    <org_study_id>CRB100706</org_study_id>
    <nct_id>NCT00331292</nct_id>
  </id_info>
  <brief_title>A Methodology Study To Look At Genes In Lung Cells And Tissue From Asthmatic Patients</brief_title>
  <official_title>A Study to Identify a Transcriptomic Profile Indicative of Cycle AMP Pathway Activation in the Lung</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GlaxoSmithKline</source>
  <brief_summary>
    <textblock>
      The primary goal of this study is to identify a gene or panel of genes which are
      differentially expressed in lung cells and tissue from asthmatic patients following
      administration of Ipratropium bromide and eiTher nebulised Albuterol or saline. Each subject
      in this study will undergo two bronchoscopies.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>August 2006</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment>30</enrollment>
  <condition>Asthma</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Have a history of intermittant asthma.

          -  Have asthma symptoms less than once per week.

          -  Have no other significant disease.

          -  Do not take regular oral or inhaled steroids.

          -  Are a non-smoker for the past 12 months with a pack history of less than 5 years.

        Exclusion criteria:

          -  Have a history of drug or alcohol abuse.

          -  Have poorly controlled asthma or a history of life-threatening asthma.

          -  Have a history of hypersensitivity to bronchodilators.

          -  Are unable to abstain from inhaled steroids from 14 days prior to the first study
             visit until completion of the study.

          -  Have received oral steroids within 3 months of study entry.

          -  Have been hospitalized for your asthma within 3 months of study entry.

          -  Have had treatment with an investigational drug within 30 days or 5 half-lives
             (whichever is longer) preceding the first dose of study medication.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>GSK Clinical Trials, MD</last_name>
    <role>Study Director</role>
    <affiliation>GlaxoSmithKline</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2008</verification_date>
  <study_first_submitted>May 26, 2006</study_first_submitted>
  <study_first_submitted_qc>May 26, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 29, 2006</study_first_posted>
  <last_update_submitted>October 15, 2008</last_update_submitted>
  <last_update_submitted_qc>October 15, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 16, 2008</last_update_posted>
  <responsible_party>
    <name_title>Study Director</name_title>
    <organization>GSK</organization>
  </responsible_party>
  <keyword>Asthma bronchoscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

